Skip to content
Search

Latest Stories

WOMEN'S HEALTH: Managing menopause in the workplace

Emily Richardson shares her views on how pharmacy teams can help women patients seeking information and support on menopause …

The menopause is a natural aging process, whereby a woman’s oestrogen level drops thus disrupting periods until they eventually stop.


A woman is said to be in the menopause when her periods have stopped for 12 months. The age when this usually occurs is between 45-55 but symptoms can begin prior to this. Symptoms vary and not all women experience them all.

They include hot flushes, vaginal dryness, joint and muscle pain, insomnia, reduced libido, urinary problems such as bladder weakness or Urinary Tract Infections (UTIs), but this list is not exhaustive.

Up to a third of women declare that the menopause affects their quality of life. It is obvious that such physical changes can have an effect on ones well-being. Women going through the menopause are at increased risk of developing depression, low self-esteem and problems with concentration (often called brain fog).

There are lots of misconceptions in the public and workplace around menopause as it is a little discussed topic. Did you know 45 per cent of women feel their menopause symptoms have had a negative impact on their work and 47 per cent of women have said that they won’t tell their employer if they need to take a day-off from work because of menopausal symptoms?

So, with women making up nearly half of the UKs workforce, have you thought about what support your workplace offers for you? And if you are an employer, what could you be doing to support your colleagues who need help during this time?

As many women say they feel embarrassed and judged in the workplace when talking about this topic, the British Menopause Society has published literature on what workplace guidance should contain to help support their workforce.

This includes:

  • Providing easy access to up-to-date information relating to the menopause, what is the menopause? Where can you seek help? What coping mechanism may help in work?
  • Employers also need to have knowledge on the topic, particularly line managers who may need to offer help and support. Line managers should have guidance on what good practice looks like when having conversations with their staff members in order to the support them individually. There should be an acknowledgement that some women may not want to talk to a younger or male member of management.
  • The guidance should address that there shouldn’t be a ‘one size fits all’ approach. The menopause is a personal experience, and as mentioned previous symptoms and severity of these vary, therefore support should be tailored to the needs of the person.
  • The guidance should acknowledge the legal liabilities workplaces have to look after the health and wellbeing of their workforce.
  • The workplace should have a policy that covers the menopause. This should include topics such as flexible working patterns, sickness absence procedures or adjusted break policies. It should also cover environmental factors such as adjustments made to seating arrangements, additional fans granted for those who need or adaptions to uniform policies.
  • The availability of support through a ‘key contact’ or named individual within the workforce to seek first help from first should be in place. To me, the above seem like obvious and reasonable wants and needs in any organisation, but how confident are you as an employer that you meet the needs of your workforce?

Another way an employer can help support their workforce is signing the ‘Menopause Workplace Pledge’, current organisations that have signed this include AstraZeneca and Royal Mail.

By signing this your pharmacy or organisation is committing to:

  • Recognising that the menopause can be an issue in the workplace and women need support
  • Talking openly, positively and respectfully about the menopause
  • Actively supporting and informing your employees affected by the menopause

Employees can also sign this pledge too, adding your name helps encourage employers to become supportive and understand potentially yourself, patients and your colleagues. For many years the menopause has been a taboo subject. I think everyone knows someone who has been affected in some way by the menopause.

In addition, I’m sure many of us have witnessed colleagues at work who could have benefitted from workplace-based support. Let’s hope more companies sign the Menopause Workplace Pledge and support their workforces if needed.

Emily Richardson is a pharmacist with Pilltime Pharmacy.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less